Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Glynn

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
British Journal of Cancer|September 21, 2013
The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistanceA P Toner, F McLaughlin, F J Giles, et al.
The Journal of Infectious Diseases|December 12, 1997
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)E L Murphy, S M Bryzman, S A Glynn, et al.
Transfusion|April 12, 2005
Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemicL H Tobler, C Bianco, S A Glynn, et al.
Oncogene|September 19, 2012
MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancerR S Hudson, M Yi, D Esposito, et al.
Transfusion|July 1, 2005
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusionS H Kleinman, S A Glynn, M J Higgins, et al.
Transfusion|August 16, 2003
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donorsP E Pellett, D J Wright, E A Engels, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
British Journal of Cancer|September 21, 2013
The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistanceA P Toner, F McLaughlin, F J Giles, et al.
The Journal of Infectious Diseases|December 12, 1997
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)E L Murphy, S M Bryzman, S A Glynn, et al.
Transfusion|April 12, 2005
Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemicL H Tobler, C Bianco, S A Glynn, et al.
Oncogene|September 19, 2012
MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancerR S Hudson, M Yi, D Esposito, et al.
Transfusion|July 1, 2005
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusionS H Kleinman, S A Glynn, M J Higgins, et al.
Transfusion|August 16, 2003
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donorsP E Pellett, D J Wright, E A Engels, et al.
Pageof 3